Literature DB >> 27102575

Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish.

Xiao Zhao1, Kristin Lorent1, Benjamin J Wilkins2, Dylan M Marchione3, Kevin Gillespie3, Orith Waisbourd-Zinman4, Juhoon So5, Kyung Ah Koo6, Donghun Shin5, John R Porter6, Rebecca G Wells1, Ian Blair3, Michael Pack1,7.   

Abstract

UNLABELLED: Biliatresone is an electrophilic isoflavone isolated from Dysphania species plants that has been causatively linked to naturally occurring outbreaks of a biliary atresia (BA)-like disease in livestock. Biliatresone has selective toxicity for extrahepatic cholangiocytes (EHCs) in zebrafish larvae. To better understand its mechanism of toxicity, we performed transcriptional profiling of liver cells isolated from zebrafish larvae at the earliest stage of biliatresone-mediated biliary injury, with subsequent comparison of biliary and hepatocyte gene expression profiles. Transcripts encoded by genes involved in redox stress response, particularly those involved in glutathione (GSH) metabolism, were among the most prominently up-regulated in both cholangiocytes and hepatocytes of biliatresone-treated larvae. Consistent with these findings, hepatic GSH was depleted at the onset of biliary injury, and in situ mapping of the hepatic GSH redox potential using a redox-sensitive green fluorescent protein biosensor showed that it was significantly more oxidized in EHCs both before and after treatment with biliatresone. Pharmacological and genetic manipulation of GSH redox homeostasis confirmed the importance of GSH in modulating biliatresone-induced injury given that GSH depletion sensitized both EHCs and the otherwise resistant intrahepatic cholangiocytes to the toxin, whereas replenishing GSH level by N-acetylcysteine administration or activation of nuclear factor erythroid 2-like 2 (Nrf2), a transcriptional regulator of GSH synthesis, inhibited EHC injury.
CONCLUSION: These findings strongly support redox stress as a critical contributing factor in biliatresone-induced cholangiocyte injury, and suggest that variations in intrinsic stress responses underlie the susceptibility profile. Insufficient antioxidant capacity of EHCs may be critical to early pathogenesis of human BA. (Hepatology 2016;64:894-907).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27102575      PMCID: PMC5251204          DOI: 10.1002/hep.28603

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Reactivity of Biliatresone, a Natural Biliary Toxin, with Glutathione, Histamine, and Amino Acids.

Authors:  Kyung A Koo; Orith Waisbourd-Zinman; Rebecca G Wells; Michael Pack; John R Porter
Journal:  Chem Res Toxicol       Date:  2016-01-13       Impact factor: 3.739

2.  Long-term survival expectancy after liver transplantation in children.

Authors:  L Migliazza; M López Santamaría; J Murcia; M Gamez; J Clavijo; C Camarena; L Hierro; E Frauca; A de la Vega; M Diaz; P Jara; J A Tovar
Journal:  J Pediatr Surg       Date:  2000-01       Impact factor: 2.545

3.  Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.

Authors:  Jittima Weerachayaphorn; Albert Mennone; Carol J Soroka; Kathy Harry; Lee R Hagey; Thomas W Kensler; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

4.  A novel keratin18 promoter that drives reporter gene expression in the intrahepatic and extrahepatic biliary system allows isolation of cell-type specific transcripts from zebrafish liver.

Authors:  Benjamin J Wilkins; Weilong Gong; Michael Pack
Journal:  Gene Expr Patterns       Date:  2014-01-03       Impact factor: 1.224

Review 5.  Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.

Authors:  Young-Sam Keum
Journal:  Ann N Y Acad Sci       Date:  2011-07       Impact factor: 5.691

6.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

7.  Congenital biliary atresia and jaundice in lambs and calves.

Authors:  P Harper; J W Plant; D B Unger
Journal:  Aust Vet J       Date:  1990-01       Impact factor: 1.281

8.  Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival.

Authors:  Danhua Zhang; Vladislav S Golubkov; Wenlong Han; Ricardo G Correa; Ying Zhou; Sunyoung Lee; Alex Y Strongin; P Duc Si Dong
Journal:  Dev Biol       Date:  2014-08-29       Impact factor: 3.582

9.  Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.

Authors:  B H Lauterburg; G B Corcoran; J R Mitchell
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

Review 10.  Biliary atresia.

Authors:  Jane L Hartley; Mark Davenport; Deirdre A Kelly
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

View more
  17 in total

1.  Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia.

Authors:  Xiao Zhao; Kristin Lorent; Diana Escobar-Zarate; Ramakrishnan Rajagopalan; Kathleen M Loomes; Kevin Gillespie; Clementina Mesaros; Michelle A Estrada; Ian A Blair; Jeffrey D Winkler; Nancy B Spinner; Marcella Devoto; Michael Pack
Journal:  Gastroenterology       Date:  2020-06-04       Impact factor: 22.682

2.  Biliary Atresia as a Disease Starting In Utero: Implications for Treatment, Diagnosis, and Pathogenesis.

Authors:  Krupa R Mysore; Benjamin L Shneider; Sanjiv Harpavat
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-10       Impact factor: 2.839

3.  Zebrafish as a Model to Study Cholestatic Liver Diseases.

Authors:  Duc-Hung Pham; Chunyue Yin
Journal:  Methods Mol Biol       Date:  2019

Review 4.  Biliatresone: progress in biliary atresia study.

Authors:  Jia-Jie Zhu; Yi-Fan Yang; Rui Dong; Shan Zheng
Journal:  World J Pediatr       Date:  2022-09-27       Impact factor: 9.186

Review 5.  Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century.

Authors:  Jorge A Bezerra; Rebecca G Wells; Cara L Mack; Saul J Karpen; Jay H Hoofnagle; Edward Doo; Ronald J Sokol
Journal:  Hepatology       Date:  2018-09       Impact factor: 17.425

Review 6.  Use of Zebrafish in Drug Discovery Toxicology.

Authors:  Steven Cassar; Isaac Adatto; Jennifer L Freeman; Joshua T Gamse; Iñaki Iturria; Christian Lawrence; Arantza Muriana; Randall T Peterson; Steven Van Cruchten; Leonard I Zon
Journal:  Chem Res Toxicol       Date:  2019-11-16       Impact factor: 3.739

7.  Using zebrafish to model liver diseases-Where do we stand?

Authors:  Duc-Hung Pham; Changwen Zhang; Chunyue Yin
Journal:  Curr Pathobiol Rep       Date:  2017-05-03

8.  Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents.

Authors:  Zhenhua Luo; Pranavkumar Shivakumar; Reena Mourya; Sridevi Gutta; Jorge A Bezerra
Journal:  Gastroenterology       Date:  2019-06-19       Impact factor: 33.883

9.  The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17.

Authors:  Orith Waisbourd-Zinman; Hong Koh; Shannon Tsai; Pierre-Marie Lavrut; Christine Dang; Xiao Zhao; Michael Pack; Jeff Cave; Mark Hawes; Kyung A Koo; John R Porter; Rebecca G Wells
Journal:  Hepatology       Date:  2016-05-20       Impact factor: 17.425

10.  Coordinated development of the mouse extrahepatic bile duct: Implications for neonatal susceptibility to biliary injury.

Authors:  Gauri Khandekar; Jessica Llewellyn; Alyssa Kriegermeier; Orith Waisbourd-Zinman; Nicolette Johnson; Yu Du; Roquibat Giwa; Xiao Liu; Tatiana Kisseleva; Pierre A Russo; Neil D Theise; Rebecca G Wells
Journal:  J Hepatol       Date:  2019-09-25       Impact factor: 30.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.